Back to company

NORDIC BIOSCIENCE A/S: Financial statements 2016

CVR: 30799968

NORDIC BIOSCIENCE A/S (CVR 30799968) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 113,880,973 and a net result of DKK 19,629,890 compared with DKK -7,423,396 the year before. That is an increase of 300.7% compared with the year before. Equity amounted to DKK 27,368,074. The solvency ratio was 15%.

Gross Profit
113,880,973 kr.
Profit/Loss
19,629,890 kr.
Equity
27,368,074 kr.
Total Assets
182,849,804 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-113.9 mio.19.6 mio.27.4 mio.-
2015-28.4 mio.-7.4 mio.7.6 mio.-
2014-21.5 mio.1.1 mio.15.2 mio.-
2013-15.8 mio.-6.7 mio.14.1 mio.-
2012-----

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NORDIC BIOSCIENCE A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

NORDIC BIOSCIENCE A/S: The 2015 annual report is outJun 3, 2016

NORDIC BIOSCIENCE A/S has published its annual report for 2015. Gross profit came to DKK 28,423,715, and the net result was DKK -7,423,396.

About NORDIC BIOSCIENCE A/S

NORDIC BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Asser Karsdal. The company is owned by NORDIC BIOSCIENCE HOLDING A/S. The company has 121 employees. In 2025, the company reported revenue of DKK 379,345,000 and a net result of DKK 96,537,000 compared with DKK 78,388,000 the year before. Equity amounted to DKK 131,205,000.